What are the treatments for partial hydatidiform mole?

After the onset of hydatidiform mole, women will experience amenorrhea, which lasts between two and three months. In addition, patients with hydatidiform mole are prone to vaginal bleeding, which begins about two to three months after menopause. Some patients will experience heavy bleeding, stretch their necks, and cause shock or death. Patients with hydatidiform mole often have an enlarged uterus and feel obvious abdominal pain, which may even cause a poisoning reaction, resulting in vomiting and edema. The following describes some of the treatments for hydatidiform mole.

Vascular aspiration: Once a hydatidiform mole is diagnosed, it should be removed immediately. The main method currently used is aspiration uterus. When suctioning the uterus, a large suction tube should be selected and used in conjunction with oval forceps. If suctioning the uterus is not possible, curettage can be performed. Preparations for blood transfusion should be made before surgery, and oxytocin should be given intravenously by adding 5-10u of oxytocin to 500ml of glucose.

Because patients with hydatidiform mole have a large uterus, thin and soft uterine walls, and abundant uterine contents, the first suction of the uterus does not emphasize complete suction to avoid perforation, heavy bleeding, etc. caused by excessive scratching. About one week after the first uterine vacuum extraction, the second curettage is performed, and the second curettage should try to clean the uterine cavity as much as possible. After the second curettage, if vaginal bleeding still does not stop, the uterus is not in good repair, and hCG does not decrease or decreases only slightly, a third curettage may be performed if there is any residual blood in the blood.

Hysterectomy: Patients over 40 years old who do not wish to have any more children may undergo hysterectomy. However, most scholars believe that patients with hydatidiform mole generally do not need hysterectomy.

Inducing labor by intramuscular injection of Trichosanthes kirilowii: It is rarely used nowadays. A skin test should be done before using the medicine and it should be used as usual. It is prohibited for patients with liver or kidney dysfunction and heart disease.

Hydatidiform mole must be treated promptly, otherwise it may lead to serious complications, such as heavy bleeding, or the need for another uterine curettage due to incomplete uterine aspiration during the treatment process. In addition, hydatidiform mole can easily lead to embolism, and even induce pulmonary edema or heart failure, all of which can threaten the patient's life.